ArticleFrontiers in cardiovascular medicine2024

A prospective randomized controlled trial to determine the safety and efficacy of extracorporeal shock waves therapy for primary prevention of subclinical cardiotoxicity in breast cancer patients without a cardiovascular risk treated with doxorubicin.

Shinjeong Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.